Rights and permissions About this article Cite this article Hsieh, MJ., Liu, HT., Wang, CN
Primary concerns include increased injection site reactions from multiple subcutaneous injections, difficulty attributing adverse effects to the correct agent, additional cost without proven benefit, and potential quality variability in compounded lipotropic products
That has literally been the mission statement since the day we opened our fucking doors
Contamination, mis-dosing, and degradation are real practical risks separate from the molecule itself
And the answer, frustratingly, is "it depends." Different peptides have different shelf lives in solution
Invest Ophthalmol Vis Sci